Skip to content

The influence of a non-invasive electrical stimulation over an area of the brain on pain and disability in patients with long-standing back pain

Effectiveness of anodal transcranial direct current stimulation (tDCS) in patients with chronic low back pain: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89874874
Enrollment
135
Registered
2011-05-05
Start date
2011-05-15
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain Musculoskeletal Diseases Dorsalgia

Interventions

1. Both groups, verum and sham stimulation, will receive 20 minutes of tDCS on 5 consecutive days 2. Sham stimulation consists of a pre-programmed validated sham paradigm, verum stimulation will be wi

Sponsors

University Medical Center Hamburg-Eppendorf (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 - 65 years, either sex 2. Categorised as suitable for a pain management programme 3. Have non-specific CLBP (with a minimum of 3 months of low back pain without any relevant ongoing pathologies such as acute disc prolapse, acute inflammation, bone fractures, spondylolisthesis or general health restrictions that require medical attention) 4. Are waiting to attend a cognitive behavioural group programme at a back pain clinic in North Germany 5. Provide written consent

Exclusion criteria

Exclusion criteria: 1. Other chronic pain syndromes 2. Spinal surgery in the past 6 month 3. Neurological disease 4. Psychiatric disease 5. Does not understand German 6. Pregnant or likely to become pregnant during the trial 7. Alcohol, drug, or medication abuse

Design outcomes

Secondary

MeasureTime frame
1. Subjective Functioning (Funktionsfragebogen Hannover) 2. Fear Avoidance Beliefs Questionnaire 3. Depression (Hospital Anxiety Depression Scale) 4. Quality of Life (SF 36) 5. Bothersomeness (5 point scale) 6. Patient Perceived Satisfactory Improvement (5 point scale) Measurements at baseline, after tDCS period, after CBT, at 4 weeks, 12 weeks and 24 weeks post CBT.

Primary

MeasureTime frame
1. Pain, measured using the Visual Analogue Scale (VAS) score (0 = no pain, 100 = unbearable pain) 2. Disability, measured using the Oswestry Disability Index 3. Measurements at baseline, after tDCS period, after CBT, at 4 weeks, 12 weeks and 24 weeks post CBT

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026